CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
This is a safety study to evaluate BOS-580 administered subcutaneously with repeated dosing over 12 weeks in Part A or 24 weeks in Part B. Part C is...
This is a randomized, double-blind, placebo-controlled, parallel-dosing, multi-center study to evaluate the efficacy and safety of Rencofilstat as ev...
Clinical trials
Research sites
Resources
Legal